Geneoscopy

Exact Sciences claims that Geneoscopy's ColoSense colorectal cancer screening assay infringes upon a patent covering Exact's Cologuard assay.

The company's data, presented at a recent meeting and simultaneously published, showed performance results analogous to currently marketed tests.